Lv51
1040 积分 2022-08-02 加入
Multidisciplinary Management of Brain Metastasis from Breast Cancer
9天前
已完结
Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges
9天前
已完结
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
9天前
已完结
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)
5个月前
已完结
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
5个月前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
7个月前
已完结
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma
9个月前
已完结
Recent Advances in the Treatment of Melanoma
9个月前
已完结
Cell atlas of the human ocular anterior segment: Tissue-specific and shared cell types
9个月前
已完结
皖公网安备34019202002308
